These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3620698

  • 21. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [Abstract] [Full Text] [Related]

  • 22. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C, Korichneva I, Devynck MA.
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [Abstract] [Full Text] [Related]

  • 23. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N, Mais DE, Halushka PV.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [Abstract] [Full Text] [Related]

  • 24. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 25. Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets.
    Murthy M, Rao GH, Robinson P, Reddy S.
    Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):31-9. PubMed ID: 7675820
    [Abstract] [Full Text] [Related]

  • 26. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
    Dorn GW, Burch RM, Kochel PJ, Mais DE, Halushka PV.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1913-7. PubMed ID: 2954555
    [Abstract] [Full Text] [Related]

  • 27. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC.
    Biochem Pharmacol; 1996 Sep 13; 52(5):763-70. PubMed ID: 8765474
    [Abstract] [Full Text] [Related]

  • 28. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
    Mais DE, Liel N, Halushka PV.
    Biochem Pharmacol; 1990 Oct 01; 40(7):1457-61. PubMed ID: 2145838
    [Abstract] [Full Text] [Related]

  • 29. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

  • 30. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
    Yun JC, Ohman KP, Gill JR, Keiser H.
    Can J Physiol Pharmacol; 1991 May 14; 69(5):599-604. PubMed ID: 1650650
    [Abstract] [Full Text] [Related]

  • 31. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.
    Praticò D, Smyth EM, Violi F, FitzGerald GA.
    J Biol Chem; 1996 Jun 21; 271(25):14916-24. PubMed ID: 8663015
    [Abstract] [Full Text] [Related]

  • 32. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE, Burch RM, Saussy DL, Kochel PJ, Halushka PV.
    J Pharmacol Exp Ther; 1985 Dec 21; 235(3):729-34. PubMed ID: 3001275
    [Abstract] [Full Text] [Related]

  • 33. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May 21; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 34. Inositol phospholipid metabolism in human platelets stimulated by ADP.
    Vickers JD, Kinlough-Rathbone RL, Packham MA, Mustard JF.
    Eur J Biochem; 1990 Oct 24; 193(2):521-8. PubMed ID: 2171937
    [Abstract] [Full Text] [Related]

  • 35. Regulation of thromboxane receptor activation in human platelets.
    Murray R, FitzGerald GA.
    Proc Natl Acad Sci U S A; 1989 Jan 24; 86(1):124-8. PubMed ID: 2521385
    [Abstract] [Full Text] [Related]

  • 36. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
    Shattil SJ, Haimovich B, Cunningham M, Lipfert L, Parsons JT, Ginsberg MH, Brugge JS.
    J Biol Chem; 1994 May 20; 269(20):14738-45. PubMed ID: 7514181
    [Abstract] [Full Text] [Related]

  • 37. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists.
    Hansen TN, Brockbank KG.
    Transfusion; 1997 Jul 20; 37(7):696-702. PubMed ID: 9225932
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA.
    Thromb Res; 1999 Sep 15; 95(6):315-23. PubMed ID: 10527409
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.